Israel cấp phép thuốc Molnupiravir của Merck, cho phép tiêm liều 4

(TTXVN/Vietnam+) 13:38 03/01/2022

Bộ Y tế Israel ngày 2/1 thông báo đã cấp phép sử dụng thuốc điều trị COVID-19 do tập đoàn dược phẩm đa quốc gia Merck của Mỹ sản xuất, sau quyết định tương tự đối với thuốc Paxlovid của Pfizer.

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